Israel cấp phép thuốc Molnupiravir của Merck, cho phép tiêm liều 4

(TTXVN/Vietnam+) 13:38 03/01/2022

Bộ Y tế Israel ngày 2/1 thông báo đã cấp phép sử dụng thuốc điều trị COVID-19 do tập đoàn dược phẩm đa quốc gia Merck của Mỹ sản xuất, sau quyết định tương tự đối với thuốc Paxlovid của Pfizer.

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